Israel cấp phép thuốc Molnupiravir của Merck, cho phép tiêm liều 4

(TTXVN/Vietnam+) 13:38 03/01/2022

Bộ Y tế Israel ngày 2/1 thông báo đã cấp phép sử dụng thuốc điều trị COVID-19 do tập đoàn dược phẩm đa quốc gia Merck của Mỹ sản xuất, sau quyết định tương tự đối với thuốc Paxlovid của Pfizer.

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